Israel cấp phép thuốc Molnupiravir của Merck, cho phép tiêm liều 4

(TTXVN/Vietnam+) 13:38 03/01/2022

Bộ Y tế Israel ngày 2/1 thông báo đã cấp phép sử dụng thuốc điều trị COVID-19 do tập đoàn dược phẩm đa quốc gia Merck của Mỹ sản xuất, sau quyết định tương tự đối với thuốc Paxlovid của Pfizer.

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